Yangtze Life Science and Technology Forum meetings are originated and hosted by DAS Capital.
The dinner meeting was initiated in April 2020 to address pertinent industry topics with CEO/co-founders/CFO from biotechnology, medical device, diagnostic and technology companies, and venture capital, private equity firms while also incorporating an element of networking.
Participation is by invitation only, and each dinner event is limited to 20-25 people to maintain an intimate and collaborative setting for presentation and discussion of relevant subjects.
The distribution list includes over 600 professionals from over 300 Yangtze Forum companies, venture capital and private equity firms.
